20
Participants
Start Date
December 1, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
May 31, 2025
Retroviral vector-transduced autologous T cells to express anti-ALPP CARs
Cyclophosphamide will be administered at dose of 20mg/kg for 1 day and then fludarabine will be given for the next 3 days with 35mg/m2 and then the CAR-T cells will be administered
RECRUITING
Department of Oncology, Xinqiao Hospital, Chongqing
TCRCure Biopharma Ltd.
INDUSTRY
Xinqiao Hospital of Chongqing
OTHER